TRANSLOCATION-ASSOCIATED SOFT TISSUE SARCOMA

Clinical trials for TRANSLOCATION-ASSOCIATED SOFT TISSUE SARCOMA explained in plain language.

Never miss a new study

Get alerted when new TRANSLOCATION-ASSOCIATED SOFT TISSUE SARCOMA trials appear

Sign up with your email to follow new studies for TRANSLOCATION-ASSOCIATED SOFT TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial aims to slow rare Cancer's spread

Disease control Recruiting now

This study tests a drug called zanzalintinib (XL092) in 29 people with advanced leiomyosarcoma that has spread or cannot be removed by surgery. The drug works by blocking signals that help cancer cells grow. The goal is to see if it can slow the cancer's progression longer than c…

Matched conditions: TRANSLOCATION-ASSOCIATED SOFT TISSUE SARCOMA

Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

TRANSLOCATION-ASSOCIATED SOFT TISSUE SARCOMA

Get alerted when new TRANSLOCATION-ASSOCIATED SOFT TISSUE SARCOMA trials appear

New drug trial aims to slow rare Cancer's spread